Global Absorbable Tissue Spacer Market Set to Experience Remarkable Growth, Projected to Surpass USD 303.8 Million by 2032 amid Rising Prostate Cancer Incidence | FMI [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
The rising prevalence of prostate cancer, particularly among older men, is a major driver of this growth. North America and Europe are expected to dominate the market, with hydrogel-based spacers leading the product type segment due to their superior efficacy and durability. Key market players are investing in research and development, forging strategic partnerships, and innovating to meet the growing needs of the healthcare sector, driving continued growth in the coming years. The radiotherapy segment is expected to witness significant market growth over the forecast period owing to factors such as the rising prevalence of cancer and the rising adoption of spacers during radiotherapy in treating various cancer types. North America Dominates the Absorbable Tissue Spacer Market and Expects to do the Same Over the Forecast Period. NEWARK, DE / ACCESSWIRE / December 9, 2024 / The global absorbable tissue spacer market is on a strong growth trajectory, with projections forecasting a s
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Should You Be Adding Boston Scientific (NYSE:BSX) To Your Watchlist Today? [Yahoo! Finance]Yahoo! Finance
- All You Need to Know About Boston Scientific (BSX) Rating Upgrade to Buy [Yahoo! Finance]Yahoo! Finance
- Interventional Cardiology Devices Market to Hit US$ 37.27 Billion by 2029 with 6.0% CAGR | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- BSX Trades Near 52-Week High: Does the Stock Hold More Potential? [Yahoo! Finance]Yahoo! Finance
- Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Truist Financial Co. from $100.00 to $110.00. They now have a "buy" rating on the stock.MarketBeat
BSX
Earnings
- 10/23/24 - Beat
BSX
Sec Filings
- 12/4/24 - Form 4
- 12/2/24 - Form 4
- 12/2/24 - Form 144
- BSX's page on the SEC website